Protein kinase C activation increases the rate and magnitude of agonist- induced delta-opioid receptor down-regulation in NG108-15 cells

S Gucker and JM Bidlack

Department of Pharmacology, University of Rochester, School of Medicine and Dentistry, New York 14642.

Protein kinase C (PKC) activation was examined for its role in delta- opioid receptor down-regulation in the neuroblastoma X glioma hybrid cell line NG108-15. Incubation of NG108-15 cells for 2 hr at 37 degrees with up to 1 microM 4 beta-phorbol 12 beta-myristate 13 alpha-acetate (PMA), a phorbol ester that activates PKC, had no effect on opioid binding to membranes prepared from these cells. However, as little as 3 nM PMA incubated with an opioid agonist and NG108-15 cells potentiated the decrease and the rate of decrease of opioid binding, compared with agonist alone. Scatchard analysis of [3H][D-Ala2,D-Leu5]enkephalin (DADLE) binding revealed that NG108-15 cells incubated for 3 hr with 1 nM DADLE and 30 nM PMA displayed a > 50% reduction in the number of [3H]DADLE binding sites with no affinity change at the remaining sites, compared with cells treated with DADLE alone. The antagonist naloxone blocked both DADLE-induced and PMA-enhanced DADLE-induced down- regulation. The agonists morphine and cyclazocine, which alone were unable to induce delta receptor down-regulation, did so in the presence of PMA. The PKC inhibitor staurosporine and down-regulation of PKC by chronic PMA treatment blocked PMA potentiation of DADLE-induced down- regulation, but not "normal" DADLE-induced down-regulation. The enhancement of down-regulation by PMA was unaffected by either metabolic inhibitor or incubations at 20 degrees, conditions that blocked down-regulation by DADLE alone. NG108-15 cells incubated with [3H]DADLE and PMA retained more [3H]DADLE than cells incubated with [3H]DADLE alone, suggesting that PMA enhanced receptor internalization instead of merely inhibiting membrane binding. The diacylglycerol 1- oleoyl-2-acetyl-glycerol and bradykinin substituted for PMA but not carbachol, indicating that PKC activated physiologically may play a role in delta receptor down-regulation.

Volume 42, Issue 4, pp. 656-665, 10/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				H. Ueda, M. Inoue, and T. Matsumoto Protein Kinase C-Mediated Inhibition of {micro}-Opioid Receptor Internalization and Its Involvement in the Development of Acute Tolerance to Peripheral {micro}-Agonist Analgesia J. Neurosci., May 1, 2001; 21(9): 2967 - 2973. [Abstract] [Full Text] [PDF]

				A. L. Burd, R. El-Kouhen, L. J. Erickson, H. H. Loh, and P.-Y. Law Identification of Serine 356 and Serine 363 as the Amino Acids Involved in Etorphine-induced Down-regulation of the µ-Opioid Receptor J. Biol. Chem., December 18, 1998; 273(51): 34488 - 34495. [Abstract] [Full Text] [PDF]

				G. Gaudriault, D. Nouel, C. Dal Farra, A. Beaudet, and J.-P. Vincent Receptor-induced Internalization of Selective Peptidicµand delta Opioid Ligands J. Biol. Chem., January 31, 1997; 272(5): 2880 - 2888. [Abstract] [Full Text] [PDF]

				S. Cvejic, N. Trapaidze, C. Cyr, and L. A. Devi Thr[IMAGE], Located within the COOH-terminal Tail of the [IMAGE] Opiate Receptor, Is Involved in Receptor Down-regulation J. Biol. Chem., February 23, 1996; 271(8): 4073 - 4076. [Abstract] [Full Text] [PDF]

				J. L. Whistler, P. Tsao, and M. von Zastrow A Phosphorylation-regulated Brake Mechanism Controls the Initial Endocytosis of Opioid Receptors but Is Not Required for Post-endocytic Sorting to Lysosomes J. Biol. Chem., August 31, 2001; 276(36): 34331 - 34338. [Abstract] [Full Text] [PDF]